(Total Views: 1202)
Posted On: 05/30/2017 5:35:59 PM
Post# of 405
5 near-term catalysts to consider:
- Announcement of EU distribution deals / Upfront money
- Results release of recent Vesele/Viagra study. Vesele sales will skyrocket IMO
- New Product launches (plus new distribution channels)...still at least 4 to come in 2017
- June 19, 2017 is the Annual Shareholder meeting. Higher PPS = Higher Morale
- FlutiCare FDA approval of ANDA (Novalere). A 2nd manufacturer !
Tweet Tweet
** Note to Investors - help yourself by NOT setting Stop Loss orders. Also, set Sell Stops in multiple dollars to "mark" your shares ! Low floater folks
- Announcement of EU distribution deals / Upfront money
- Results release of recent Vesele/Viagra study. Vesele sales will skyrocket IMO
- New Product launches (plus new distribution channels)...still at least 4 to come in 2017
- June 19, 2017 is the Annual Shareholder meeting. Higher PPS = Higher Morale
- FlutiCare FDA approval of ANDA (Novalere). A 2nd manufacturer !
Tweet Tweet
** Note to Investors - help yourself by NOT setting Stop Loss orders. Also, set Sell Stops in multiple dollars to "mark" your shares ! Low floater folks
(1)
(0)
